Erector Spinae Plane Block Reduces Postoperative Pain Following Laparoscopic Colorectal Operation
NCT ID: NCT04238780
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-02-20
2023-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Visceral Analgesic Effect of Erector Spinae Plane Block in Laparoscopic Cholecystectomy
NCT03767816
Effect of Bilateral Erector Spinae Plan Block in Colorectal Surgery
NCT05256953
Effect of the Erector Spinae Plane Block in on Robotic Colorectal Surgery
NCT07185607
Erector Spinae Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia After Laparoscopic Resection of Colorectal Cancer.
NCT05574283
Efficacy of Ultrasound Guided Erector Spinae Plane Block
NCT04371705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ESP( Erector Spinae Plane Block)
After induction parturient in the ESPB underwent bilateral ESPB at the level of T7 using a linear ultrasound (US) transducer.
Intravenous fentanyl patient control device 24-hour fentanyl consumption will be recorded.
Erector Spinae Plane Block
The transducer was placed vertically 3cm lateral to the midline to visualize the muscles of the back, transverse process and the pleura in between the two transverse processes. After local infiltration of the needle insertion site with 2-3 ml of 2% lidocaine needle was inserted in cranial-caudal direction towards the transvers process using in plane technique until the needle cross all the muscles then interfascial injection of 20ml local anesthetics is done after ensuring negative aspiration, the procedure was repeated following the same steps on the other side of the back.
Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.
control group
No regional anesthesia technique will be applied to the control group.
Intravenous fentanyl patient control device 24-hour fentanyl consumption will be recorded.
Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector Spinae Plane Block
The transducer was placed vertically 3cm lateral to the midline to visualize the muscles of the back, transverse process and the pleura in between the two transverse processes. After local infiltration of the needle insertion site with 2-3 ml of 2% lidocaine needle was inserted in cranial-caudal direction towards the transvers process using in plane technique until the needle cross all the muscles then interfascial injection of 20ml local anesthetics is done after ensuring negative aspiration, the procedure was repeated following the same steps on the other side of the back.
Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gachon University Gil Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung Ju Choi
assistance professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hyunjeong kwack, md,phd
Role: STUDY_DIRECTOR
Gachon University Gil Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gachon University College of Medicine, Gil Hospital
Incheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
hyung jeong kwak, MD,PHD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESPlapaAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.